...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Free
Message: A simple question....is Saturday make or break?

This is what gives me comfort.

My takeaways from the AGM (subjective, of course): The data is pretty good, and we'll probably have a bolt-on trial.

If the data is good enough that RVX can design a bolt-on trial with a high degree of probability to get the necessary patient-years (with a reasonably high margin of error), then this stock will be massively de-risked and then it's mostly just a question of time.

Even without considering CKD/Cognition I think November 18 will be a very good day. December 5 might be a nice double-whammy.

Share
New Message
Please login to post a reply